CLINICAL_TRIALS
trial_result
· 2013-05-27
Clinical Trial Update: Single Injection of REGN475/SAR164877 in the Treatment of Chronic Pancreatitis Pain [Phase 2]
Summary
A Phase 2 trial evaluating REGN475/SAR164877 for chronic pancreatitis pain has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Regeneron Pharmaceuticals | Conditions: Abdominal Pain Upper | Phase 2 | Status: TERMINATED